Oppenheimer Weighs in on LHC Group, Inc.’s Q1 2019 Earnings (LHCG)

LHC Group, Inc. (NASDAQ:LHCG) – Research analysts at Oppenheimer issued their Q1 2019 earnings estimates for LHC Group in a research report issued to clients and investors on Tuesday. Oppenheimer analyst M. Wiederhorn anticipates that the health services provider will post earnings of $0.66 per share for the quarter. Oppenheimer currently has a “Buy” rating and a $85.00 price target on the stock. Oppenheimer also issued estimates for LHC Group’s Q2 2019 earnings at $0.77 EPS, Q3 2019 earnings at $0.77 EPS, Q4 2019 earnings at $0.82 EPS and FY2019 earnings at $3.01 EPS.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million during the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The company’s revenue was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.54 EPS.

Other analysts also recently issued research reports about the stock. Zacks Investment Research downgraded shares of LHC Group from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. William Blair restated an “outperform” rating on shares of LHC Group in a research report on Tuesday, November 21st. Craig Hallum restated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a research report on Tuesday, November 7th. Jefferies Group boosted their price objective on shares of LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a research report on Tuesday, November 7th. They noted that the move was a valuation call. Finally, BidaskClub downgraded shares of LHC Group from a “sell” rating to a “strong sell” rating in a research report on Thursday, December 7th. Two analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $77.10.

Shares of LHC Group (LHCG) traded up $1.00 during trading hours on Wednesday, hitting $65.86. 241,641 shares of the stock traded hands, compared to its average volume of 289,600. The stock has a market cap of $1,200.00, a P/E ratio of 28.39, a PEG ratio of 1.69 and a beta of 0.70. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a twelve month low of $44.13 and a twelve month high of $76.14.

A number of hedge funds have recently added to or reduced their stakes in the stock. Federated Investors Inc. PA raised its position in LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in LHC Group by 3.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 12,254 shares of the health services provider’s stock valued at $832,000 after purchasing an additional 372 shares during the last quarter. Acrospire Investment Management LLC raised its position in LHC Group by 30.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after purchasing an additional 400 shares during the last quarter. Thrivent Financial For Lutherans raised its position in LHC Group by 8.6% in the 2nd quarter. Thrivent Financial For Lutherans now owns 9,100 shares of the health services provider’s stock valued at $618,000 after purchasing an additional 720 shares during the last quarter. Finally, American International Group Inc. raised its position in LHC Group by 7.2% in the 3rd quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock valued at $889,000 after purchasing an additional 840 shares during the last quarter. Hedge funds and other institutional investors own 85.41% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/01/17/oppenheimer-weighs-in-on-lhc-group-inc-s-q1-2019-earnings-lhcg.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply